Emer Currie (Dublin West, Fine Gael)
Link to this: Individually | In context

1026. To ask the Minister for Health the measures her Department is taking to expand access to IVF for individuals with a condition (details supplied); and if she will make a statement on the matter. [63104/25]

Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context

The Model of Care for Fertility was developed by the Department of Health in conjunction with the HSE’s National Women & Infants Health Programme to ensure that fertility-related issues are addressed through the public health system at the lowest level of clinical intervention necessary.

Referrals for publicly-funded, privately-provided assisted human reproduction (AHR) treatment commenced in September 2023, subject to patients meeting the criteria agreed by the Department and the HSE. The access criteria were developed by a multi-disciplinary group, with reproductive medicine expertise and followed consultation with experts in the field along with a review of the international evidence. These criteria are in keeping with those applied in other jurisdictions.

The clinical parameters of the access criteria include an assessment of as age, body mass index (BMI) and other health and well-being elements.

The clinical parameters of BMI were reviewed and determined in the context of both the potential success of the advanced fertility treatment but also the health and well-being of the intending birth mother and any resultant pregnancy, inclusive of the management of maternity care, delivery and health of a child. While it is recognised that there may be medical conditions which contribute to a high BMI, the access criteria do not offer exemptions for AHR referrals.

Up to 10 November 2025, over 3,300 couples have been referred by a Reproductive Specialist Consultant for AHR treatment, following extensive investigations and/or secondary level treatment within the Regional Fertility Hubs. Furthermore, the Hubs have successfully and directly managed thousands more patients presenting with fertility-related issues who have been referred by their GP. Not all couples experiencing fertility challenges actually require such advanced and invasive interventions as IVF.

In this regard, it is important to note that the access criteria for public patients to avail of services provided at a Regional Fertility Hub are less stringent than those required to be met in order to avail of free AHR treatment. For example, the maximum BMI for a woman to access services at a Hub is 35.0 kg/m2, instead of 30.0 kg/m2.

Therefore, it is advised that if a couple is experiencing fertility challenges, and they meet the access criteria for care and management at Regional Fertility Hub level, then they should seek a referral from their GP. Each Regional Fertility Hub is positioned to provide a suite of investigations and tests free of charge and can commence working with the couple to identify next appropriate clinical steps, many of which may be available within the Hub itself or by means of a referral to another public service.

The access criteria and the terms of the AHR treatment initiative are being kept under ongoing review. Further potential changes to the access criteria or expansion of the initiative requires continued extensive consultation between Department officials, colleagues in the HSE, and also with relevant specialists in the field of reproductive medicine. This will include consideration of additional funding requirements which may ensue from any proposed expansion of the initiative.

I want to reassure you that my Department and the Government are focused, through the full implementation of the Model of Care for Fertility, on ensuring that patients receive care at the appropriate level of clinical intervention and then those requiring, and eligible for, advanced AHR treatment such as IVF will be able to access same through the most effective deployment of finite public resources.

Sorca Clarke (Longford-Westmeath, Sinn Fein)
Link to this: Individually | In context

1027. To ask the Minister for Health if a group (details supplied) holds any official authorised role to collect, process, or manage patient data on behalf of the Women’s Health Framework, the Department of Health, or the HSE; and if so, to outline the legal and administrative basis for such an arrangement. [63105/25]

Sorca Clarke (Longford-Westmeath, Sinn Fein)
Link to this: Individually | In context

1028. To ask the Minister for Health if she will publish the governance structure, data protection impact assessment and data protection processes associated with any collection or storage of patient information under a project (details supplied) or any related element of the Women’s Health Framework. [63106/25]

Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context

I propose to take Questions Nos. 1027 and 1028 together.

The group referred to by the Deputy does not operate under the remit of my Department and as such I have no role in its operation, activities or governance.

The Endometriosis Priority Actions Advisory Group was established in September 2025 to improve women’s health outcomes and experiences of women with endometriosis. The advisory group has been established under the umbrella of the Women’s Health Taskforce. The establishment of this group arose from priorities identified following the Endometriosis Patient Forum held on the 1st September 2025.

The advisory group consists of existing members of the Women’s Health Taskforce, officials from relevant policy areas in my Department, representation of the HSE’s National Women and Infants Health Programme, the National Women’s Council and endometriosis advocates. I am aware that a representative of the group referred by the Deputy is one of five endometriosis advocates on the advisory group. The voice of women is tantamount to the work of the Women’s Health taskforce and the inclusion of these advocates on the advisory group is fundamental to its remit.

The advisory group has a key role to play in advising on and the oversight of specific actions set out in the group’s terms of reference.

The views of all women and girls affected by endometriosis are important to me and the Women’s Health Taskforce. I will continue to listen to women to hear about their experiences with a view to continuing the work we to improve health outcomes for women and girls.